Single Immunizing Dose of Recombinant Adenovirus Efficiently Induces CD8+ T Cell-Mediated Protective Immunity Against Malaria

Journal of Immunology

Volumn 158, Issue 3, 1997, Pages 1268-1274

  Rodrigues, Elaine G ^a   Zavala, Fidel ^a   Eichinger, Daniel ^a   Wilson, James M ^b,c   Tsuji, Moriya ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; PARASITE ANTIGEN; PEPTIDE; PROTOZOON ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DOSE RESPONSE; FEMALE; IMMUNOLOGY; LIVER; LYMPHOCYTE DEPLETION; MALARIA; MOLECULAR GENETICS; MOUSE; PARASITOLOGY; PLASMODIUM YOELII; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; IMMUNITY, CELLULAR; LIVER; LYMPHOCYTE DEPLETION; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; PLASMODIUM YOELII; T-LYMPHOCYTE SUBSETS;

EID: 0031065201     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ertl, H. C. J., and Z. Xiang. 1996. Novel vaccine approaches. J. Immunol. 156: 3579.
2. Kumar, S., L. Miller, I. Quakyi, D. Keister, R. Houghten, W. Maloy, B. Moss, J. Berzofsky, and M. Good. 1988. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature 334:258.
3. + cytotoxic T cells. J. Exp. Med. 172:1083.
4. 8+ T-cell-mediated protective immunity against malaria. Proc. Natl. Acad. Sci. USA 90:5214.
5. Graham, H. L., and L. Prevec. 1992. Adenovirus-based expression vectors and recombinant vaccines. In: Vaccines. New Approaches to Immunological Problems. R. W. Ellis, ed. Butterworth-Heinemann, Newton, MA, p. 363.
6. Crystal, R. G. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science 270:404.
7. Top, F. H., Jr., E. L. Buescher, W. H. Bancroft, and P. K. Russell. 1971. Immunization with live type 7 and 4 vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J. Infect. Dis. 124:155.
8. Top, F. H., Jr. 1975. Control of adenovirus acute respiratory disease in U.S. Army trainees. Yale J. Biol. Med. 48:185.
9. Chaloner-Larsson, G., G. Contrearas, and J. Furesz. 1986. Immunization of Canadian Armed Forces personnel with live types 4 and 7 adenovirus vaccines. Can. J. Public Health 77:367.
10. Jaffe, H. A., G. Danel, G. Longenecker, M. Metzger, Y. Setoguchi, M. A. Rosenfeld, T. W. Gant, S. S. Thorgeirsson, L. D. Stratford-Perricaudet, M. Perricaudet, A. Pavirani, J. P. Lecocq, and R. G. Crystal. 1992. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat. Genet. 1:372.
11. Imler, J. L. 1995. Adenovirus vectors as recombinant viral vaccines. Vaccine 13:1143.
12. Eloit, M., P. Gilardi-Hebenstreit, B. Toma, and M. Perricaudet. 1990. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. J. Gen. Virol. 71:2425.
13. Fooks, A. R., E. Schadeck, V. G. Liebert, A. B. Dowsett, B. K. Rima, M. Steward, J. R. Stephenson, and G. W. G. Wilkinson. 1995. High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 210:456.
14. Ragot, T., S. Finerty, P. E. Watkins, M. Perricaudet, and A. J. Morgan. 1993. Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/22U induces protective immunity against EBV-induced lymphomas in the cottontop tamarin. J. Gen. Virol. 74:501.
15. Xiang, Z. Q., Y. Yang, J. M. Wilson, and H. C. J. Ertl. 1996. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220.
16. Juillard, V, P. Villefroy, D. Godfrin, A. Pavirani, A. Venet, and J.-G. Guillet. 1995. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur. J. Immunol. 25:3467.
17. Gallichan, W. S., D. C. Johnson, F. L. Graham, and K. L. Rosenthal. 1993. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J. Infect. Dis. 168:622.
18. Nardin, E. H., and R. S. Nussenzweig. 1993. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11:687.
19. Nussenzweig, V., and R. S. Nussenzweig. 1989. Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 45:283.
20. + T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664.
21. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 85:573.
22. + T cells to sporozoite-induced protection against malaria. Immunology 80:1.
23. Romero, P., J. L. Mariyanski, G. P. Corradin, R. S. Nussenzweig, V. Nussenzweig, and F. Zavala. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341: 323.
24. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 3:579.
25. + T cell clones against Plasmodium yoelii liver stages. J. Immunol. 150:1471.
26. + cytolytic T cell clone confers protection against murine malaria. J. Exp. Med. 172:1353.
27. Davidson, B. L., E. D. Allen, K. F. Kozarsky, J. M. Wilson, and B. J. Roessler. 1993. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat. Genet. 3:219.
28. Vanderberg, J. P., and R. Gwadz. 1980. The transmission by mosquitoes of plasmodia in the laboratory. In Research in Malaria, Vol. 2. J. Kreier, ed. Academic Press, New York, p. 153.
29. Grillot, D., M. Michel, I. Muller, C. Tougne, L. Renia, D. Mazier, G. Corradin, P. H. Lambert, J. A. Louis, and G. Del Giudice. 1990. Immune responses to defined epitopes on the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii. Eur. J. Immunol. 20:1215.
30. Tsuji, M., G. Corradin, and Zavala, F. 1992. Monoclonal antibodies recognize a processing dependent epitope present in the mature CS protein of various plasmodial species. Parasite Immunol. 14:457.
31. Yang, Y., F. A. Nunes. K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407.
32. Huard, J., H. Lochmuller, G. Acsadi, A. Jani, B. Massie, and G. Karpati. 1995. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2:107.
33. Goossens, P. L., H. Jouin, G. Marchal, and G. Milon. 1990. Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver. J. Immunol. Methods 132:137.
34. + T cells using an ELISPOT assay. J. Immunol Methods 181:45.
35. 1 phase of cell cycle produce IFN-γ and IL-5. J. Immunol. 150:106.
36. + T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. Exp. Parasitol. 84:223.
37. Tsuji, M., D. Mattei, R. S. Nussenzweig, D. Eichinger, and F. Zavala. 1994. Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol. Res. 80:16.
38. Arreaza, G., V. Corredor, and F. Zavala. 1991. Plasmodium yoelii: quantification of the exoerythrocytic stages based on use of ribosomal RNA probes. Exp. Parasitol. 72:103.
39. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
40. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866.
41. + T cells to sporozoite-induced protection against malaria. Immunology 80:1.
42. Jaffe, H. A., C. Daniel, G. Longenecker, M. Metzger, Y. Setoguchi, M. A., Rosenfeld, T. W. Gant, S. S. Thorgeirsson, L. D. Stratford-Perricaudet, M. Perricaudet, A. Pavirani, J.-P. Lecocq, and R. G. Crystal. 1992. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat. Genet. 1:372.
43. Acsadi, G., A. Jani, B. Massie, M. Simoneau, P. Holland, K. Blaschuk, and G. Karpati. 1994. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3:579.
44. Yang, Y., F. A. Nunes, K. Berencsi, E. Gonczol, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:362.